Aegerion To Pay $35M To Settle Criminal, False Claims Cases, $4M To Settle SEC Action

(September 25, 2017, 12:26 PM EDT) -- BOSTON — Aegerion Pharmaceuticals Inc. will pay more than $35 million to resolve federal criminal misdemeanor charges and civil claims that it promoted its expensive cholesterol drug Juxtapid for off-label uses...
To view the full article, register now.